ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 13 filers reported holding ARIDIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $98,205 | -30.0% | 446,588 | 0.0% | 0.19% | -39.3% |
Q1 2023 | $140,273 | -73.4% | 446,588 | 0.0% | 0.32% | -75.6% |
Q4 2022 | $526,974 | +27.0% | 446,588 | 0.0% | 1.30% | +45.3% |
Q3 2022 | $415,000 | -15.5% | 446,588 | 0.0% | 0.90% | -6.1% |
Q2 2022 | $491,000 | -37.5% | 446,588 | 0.0% | 0.96% | -24.7% |
Q1 2022 | $786,000 | -24.5% | 446,588 | 0.0% | 1.27% | -8.5% |
Q4 2021 | $1,041,000 | -18.6% | 446,588 | +28.5% | 1.39% | -18.1% |
Q3 2021 | $1,279,000 | -36.7% | 347,517 | +27.3% | 1.69% | -28.2% |
Q2 2021 | $2,019,000 | +54.0% | 272,886 | +22.8% | 2.36% | +24.5% |
Q1 2021 | $1,311,000 | – | 222,222 | – | 1.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VICTORY CAPITAL MANAGEMENT INC | 934 | $6,000 | 0.00% |
UBS Group AG | 1,025 | $7,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 300 | $2,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 25,569 | $171,000 | 0.00% |
MORGAN STANLEY | 229 | $2,000 | 0.00% |
BlackRock Inc. | 1,222 | $8,000 | 0.00% |
VANGUARD GROUP INC | 81,966 | $551,000 | 0.00% |